azacitidine has been researched along with Cardiomegaly in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baugh, JA; Neary, R; Russell-Hallinan, A; Watson, CJ | 1 |
| Baugh, J; Corrigan, N; Glezeva, N; Horgan, S; Ledwidge, M; McDonald, K; Neary, R; Tea, I; Watson, CJ | 1 |
2 other study(ies) available for azacitidine and Cardiomegaly
| Article | Year |
|---|---|
Repurposing From Oncology to Cardiology: Low-Dose 5-Azacytidine Attenuates Pathological Cardiac Remodeling in Response to Pressure Overload Injury.
Topics: Animals; Azacitidine; Cardiomegaly; DNA Methylation; Drug Repositioning; Electrocardiography; Hematologic Neoplasms; Male; Mice; Mice, Inbred C57BL | 2021 |
Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis.
Topics: Actins; Animals; Azacitidine; Cardiomegaly; Carrier Proteins; Cells, Cultured; Collagen Type I; Collagen Type III; Disease Models, Animal; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Male; Myocytes, Cardiac; Rats, Inbred SHR; Rats, Inbred WKY; Transforming Growth Factor beta1; Ventricular Remodeling | 2016 |